COLUMBIA, Md., Jan. 4 Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the Needham Growth Conference which is scheduled to take place January 12-14, 2010 at the New York Palace Hotel in New York City. Peter L. Buzy, Chief Financial Officer, is scheduled to present on Tuesday, January 12(th) at 1:50 p.m. Eastern Time.
Advertisement
A live audio webcast of Martek's presentation can be accessed at: http://www.wsw.com/webcast/needham35/matk/
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
Contact: Kyle Stults Investor Relations (410) 740-0081
SOURCE Martek Biosciences Corporation
